Tspo
Showing 1 - 25 of 105
Lung in Pulmonary Artery Hypertension (PAH)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Healthy
- TSPO PET scan (11C-PBR28)
- (no location specified)
Feb 16, 2023
Healthy Trial run by the National Institute of Mental Health (NIMH) (18F-SF12051)
Recruiting
- Healthy
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Using TSPO
Recruiting
- Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection
- PET Tracer
- +2 more
-
New York, New YorkNYU Langone Health
Nov 7, 2022
HIV Associated Neurocognitive Disorder, HIV Dementia, HIV Encephalitis Trial (SV2A PET, TSPO PET)
Not yet recruiting
- HIV Associated Neurocognitive Disorder
- +3 more
- SV2A PET
- TSPO PET
- (no location specified)
Oct 16, 2022
Parkinson Disease Trial in Birmingham (DPA-714-PET/MRI)
Recruiting
- Parkinson Disease
-
Birmingham, AlabamaUAB Advanced Imaging Facility
Mar 29, 2022
Autoimmune Encephalomyelitis Trial in Shanghai (18F-DPA-714 PET)
Recruiting
- Autoimmune Encephalomyelitis
- 18F-DPA-714 PET
-
Shanghai, ChinaRuijin Hospital
Mar 15, 2022
Stroke, Ischemic, Inflammatory Response, Stroke, Acute Trial in London (Brain Imaging)
Completed
- Stroke, Ischemic
- +2 more
- Brain Imaging
-
London, United KingdomImperial College London
Jun 10, 2021
Ischemic Stroke Trial in Munich ([18F]-GE-180 PET, 3T MRI, immune cell profiling in blood)
Recruiting
- Ischemic Stroke
- [18F]-GE-180 PET
- +2 more
-
Munich, Germany
- +1 more
Oct 5, 2021
Blast Exposure on Special Operations Forces Service Members
Recruiting
- Traumatic Brain Injury
- Blast Injuries
- 3T Connectome MRI
- +5 more
-
Boston, MassachusettsMassachusetts General Hospital
Dec 20, 2021
Neurotropism and Neuroinflammation in COVID-19 Delirium.
Recruiting
- Covid19
- +2 more
- serology testing profiles description
- +4 more
-
Toulouse, France
- +1 more
Sep 3, 2021
Microglia in the Pathogenesis of Progressive Multiple Sclerosis
Active, not recruiting
- Multiple Sclerosis
-
Turku, Finland Proper, FinlandTurku PET Centre
Oct 12, 2022
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's
Recruiting
- Alzheimer Disease
- Healthy
- Positron Emission Tomography (PET) using two PET tracer under IND
-
Houston, TexasHouston Methodist Research Institute
Jan 20, 2023
Critical Asymptomatic Carotid Artery Disease, Non-Critical Asymptomatic Carotid Artery Disease Trial in Birmingham
Recruiting
- Critical Asymptomatic Carotid Artery Disease
- Non-Critical Asymptomatic Carotid Artery Disease
-
Birmingham, AlabamaUAB
Dec 13, 2022
SARS CoV-2 Post-Acute Sequelae Trial in Birmingham (DPA-714 PET/MRI)
Not yet recruiting
- SARS CoV-2 Post-Acute Sequelae
- DPA-714 PET/MRI
-
Birmingham, AlabamaUAB
Dec 16, 2022
Microglial Activation in the CNS
Active, not recruiting
- Multiple Sclerosis
- Imaging
-
Turku, Finland Proper, FinlandTurku PET Centre
May 31, 2022
Alzheimer Trial in New York (11C-ER176, 18F-florbetaben)
Recruiting
- Alzheimer Disease
-
New York, New YorkColumbia University Irving Medical Center
Jan 10, 2022
Does Microglial Activation Promote Lesion Growth and Progression
Enrolling by invitation
- Multiple Sclerosis
-
Turku, Finland Proper, FinlandTurku PET Centre
Nov 1, 2022
Healthy Trial in New Haven (Lipopolysaccharide)
Completed
- Healthy
- Lipopolysaccharide
-
New Haven, ConnecticutYale University
Jul 14, 2022
Longitudinal Tracking of Patients Diagnosed With
Not yet recruiting
- Neurodegenerative Diseases
- +4 more
- (no location specified)
Aug 16, 2022
Multiple System Atrophy, Multiple System Atrophy, Cerebellar Variant, Multiple System Atrophy, Parkinson Variant (Disorder)
Completed
- Multiple System Atrophy
- +3 more
-
Boston, MassachusettsMovement Disorders Clinic, 60 Fenwood Road
Aug 18, 2022
Post Traumatic Stress Disorder Trial in New Haven (Lipopolysaccharide)
Recruiting
- Post Traumatic Stress Disorder
-
New Haven, ConnecticutYale University
Dec 6, 2022
Brain Tumor, Medulloblastoma Trial in Memphis ([18F]DPA714)
Recruiting
- Brain Tumor
- Medulloblastoma
-
Memphis, TennesseeSt.Jude Children's Research Hospital
Aug 17, 2022
Schizophrenia Trial in London (Natalizumab, Placebo: normal saline)
Recruiting
- Schizophrenia
- Natalizumab
- Placebo: normal saline
-
London, United KingdomInstitute of Psychiatry, Psychology and Neuroscience, King's Col
Sep 27, 2022
COVID-19 Trial in Amsterdam ([18F]DPA-714 positron emission tomography (PET) scan)
Enrolling by invitation
- COVID-19
- [18F]DPA-714 positron emission tomography (PET) scan
-
Amsterdam, NetherlandsVU University Medical Center
May 11, 2022